What is the management approach for patients with a high gallbladder ejection fraction (EF)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Patients with High Gallbladder Ejection Fraction

Patients with biliary symptoms and a high gallbladder ejection fraction (EF >80%) should be considered for laparoscopic cholecystectomy, as this can lead to significant symptomatic relief in approximately 75-85% of cases. 1, 2, 3

Diagnostic Criteria and Evaluation

  • Biliary hyperkinesia is defined as a gallbladder ejection fraction (EF) greater than 80-81% on cholecystokinin (CCK)-stimulated hepatobiliary iminodiacetic acid (HIDA) scan in patients with biliary symptoms 2
  • Patients typically present with:
    • Postprandial right upper quadrant pain (biliary colic) 4, 1
    • Nausea and vomiting (present in approximately 64% of cases) 3
    • Chronic diarrhea (present in approximately 31% of cases) 3
  • Initial evaluation should include:
    • Normal abdominal ultrasound (absence of gallstones, sludge, or gallbladder wall thickening) 1
    • CCK-HIDA scan showing elevated EF (>80%) 1, 2, 3
    • Reproduction of symptoms during CCK infusion (occurs in approximately 75% of patients) 1

Treatment Approach

  • Laparoscopic cholecystectomy is the recommended treatment for patients with biliary symptoms and high gallbladder EF (>80%) 1, 2, 3
  • Expected outcomes after cholecystectomy:
    • Complete symptom resolution: 61-85% of patients 1, 3
    • Partial symptom improvement: 15% of patients 1, 3
    • Overall improvement rate (complete or partial): 76-94% of patients 1, 3

Prognostic Factors

  • Higher gallbladder ejection fraction is associated with better outcomes:
    • Patients with complete symptom resolution had a median EF of 94% compared to 88% in those without complete resolution 3
    • An EF cutoff of 81% is significantly associated with pain resolution after cholecystectomy (78.2% for EF ≥81% vs 60.0% for EF <81%) 2
  • Pathological findings:
    • Chronic cholecystitis is found in 61-73% of specimens despite normal imaging 1, 2, 3
    • Other findings include cholesterolosis (22%) and polyps (3.4%) 1

Clinical Considerations and Caveats

  • Biliary hyperkinesia is a relatively uncommon condition, representing approximately 2.8% of all cholecystectomy cases 1
  • The concept of biliary hyperkinesia is still evolving, with less literature available compared to hypokinetic biliary dyskinesia (EF <40%) 4, 5, 3
  • Patients should be informed that while success rates are good, approximately 15-24% may not experience complete symptom resolution 1, 3
  • The presence of unexpected pathologic findings in 94% of specimens supports the biological basis for this condition 1

Follow-up

  • Patients should be evaluated at 2 weeks post-surgery for initial assessment of symptom improvement 1
  • Long-term follow-up (10-16 months) is recommended to assess durability of symptom relief 1

While biliary hyperkinesia is less established than hypokinetic biliary dyskinesia as an indication for cholecystectomy, emerging evidence supports surgical intervention in carefully selected patients with typical biliary symptoms and high gallbladder ejection fraction.

References

Research

Defining Biliary Hyperkinesia and the Role of Cholecystectomy.

Journal of the American College of Surgeons, 2023

Research

Biliary and gallbladder dyskinesia.

Current treatment options in gastroenterology, 2007

Research

Biliary Dyskinesia.

Current treatment options in gastroenterology, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.